secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001628280-24-010569
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology Q3 revenue down 6% to $12.0M; operating loss widens to $2.6M
-------------------------------------------------------------------------------

- Q3 FY2024 revenue $12.0M, down from $12.8M YoY; gross margin fell to 34.7% from 39.7%.
- Operating loss of $2.6M vs $2.5M a year ago; adjusted EBITDA loss of $1.7M.
- Nine-month revenue $36.2M, down 11.4%; operating loss of $7.1M vs $2.7M loss YoY.
- Cash and equivalents $4.5M at quarter end; no debt outstanding.
- Company seeking capital for Corellia AI subsidiary; two lead targets progress toward licensing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828024010569/0001628280-24-010569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828024010569/csbr-20240312.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-010569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer